FIG 5.
Efficacy in all patients with BRCA alterations (BRCA+) detected by central plasma or tissue testing, regardless of enrollment assay. Patient groups overlap but are not identical: 61 patients were identified as BRCA+ by central plasma test (A) and 59 patients were identified as BRCA+ by central tissue test (B). Bars were capped at 100% for visual clarity. PSA increases for the 3 leftmost patients in panel A were 689%, 231%, and 183%.